Printer Friendly
The Free Library
14,694,118 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Interleukins topic

Subtopics (11)

 

Articles

1-67 out of 67 article(s)
Title Author Type Date Words
Cytheris Announces Initiation of CONVERT, a Phase I/IIa Study of Recombinant Human Interleukin-7 (CYT107) in Combination with Antiviral Therapy and Vaccination for Treatment of Chronic Hepatitis B Virus. Dec 8, 2009 1429
Cytheris Announces Initiation of NCI/NIH-Sponsored Phase I/IIa Clinical Study of Tumor Vaccination and Interleukin-7 (IL-7) in Patients with High Risk Pediatric Solid Tumors. Nov 23, 2009 1136
Treating HIV-AIDS with interleukin-2 'ineffective'. Oct 21, 2009 317
Treating HIV-AIDS with interleukin-2 'ineffective'. Oct 18, 2009 317
Cytheris Announces Initiation of NIAID/NIH-Sponsored Phase I/IIa Clinical Trial of Interleukin-7 (IL-7). Oct 14, 2009 1687
Cytheris Announces Interim Data from INSPIRE Study Showing Interleukin-7 (CYT107) Induces Dose-Dependent and Sustained Increase of CD4 T Cells in Chronic HIV-Infected Patients. Sep 15, 2009 1163
Cytheris Announces Notice of Allowance for U.S. Patent Covering the Pharmaceutical Composition of Its Recombinant Human Interleukin-7 (CYT107). Jul 8, 2009 1005
Regeneron Converts Interleukin-1 Antibody Opt-In Rights to Royalty Agreement. Jun 11, 2009 515
Effects of acute moderate and strenuous exercise bouts on IL-17 production and inflammatory response in trained rats. Duzova, Halil; Karakoc, Yunus; Emre, Memet Hanifi; Dogan, Zumrut Yilmaz; Kilinc, Evren Report Jun 1, 2009 3784
ZymoGenetics Reports Encouraging Phase 2 Results in Renal Cell Cancer for IL-21 with Nexavar[R]. Financial report May 31, 2009 774
Cytheris Announces Publication of Preclinical Study in Nature Medicine Showing Combination of Interleukin-7 with Viral Vaccine Boosts Immunity to Tumors. May 26, 2009 1127
Final Phase 2 Results for IL-21 in Renal Cell Cancer Show Tolerability and Enhanced Efficacy of Nexavar Combination. May 14, 2009 532
ZymoGenetics Reports Encouraging Preliminary Results from Phase 2 Study of IL-21 in Metastatic Melanoma Conducted by NCIC. May 13, 2009 566
Cytheris Announces Publication of IL-7 Primate Study Showing Rapid and Massive T Cell Homing to the Gut. May 12, 2009 1558
Reportlinker Adds World Growth Factors (Blood and Tissue) Market Report. Mar 24, 2009 3865
Cytheris Announces Publication of IL-7 HIV Data in The Journal of Clinical Investigation. Mar 17, 2009 1775
Tests identify the immune proteins that defend against West Nile virus: mice without the proteins are more susceptible to pathogen. Seppa, Nathan Feb 28, 2009 532
Research and Markets: Repositioning of Interleukin-1 as an Anti-Inflammatory Target. Feb 16, 2009 372
ZymoGenetics Secures Worldwide Rights to IL-21. Jan 28, 2009 529
Key Challenges and Issues facing the World Growth Factors (Blood And Tissue) Market. Jan 8, 2009 3786
Cytheris Initiates Asian Phase I/IIa Clinical Trial of Interleukin-7 (IL-7) as an Immunotherapy in HCV Patients. Oct 28, 2008 1583
ZymoGenetics Presents Interim IL-21 Phase 2 Results in Renal Cell Cancer. Oct 22, 2008 806
Dutton Associates Announces Investment Opinion: Interleukin Genetics Rating Maintained at Strong Speculative Buy in Update Coverage by Dutton Associates. Sep 10, 2008 488
Resolvyx Scientific Advisors Publish First In-Vivo Data Showing Resolvins Suppress IL-23 and IL-17, Key Mediators of Inflammatory Disease. Jul 3, 2008 625
A Brief Report Describing the Scientific Rationale in Developing Molecules Targeting Interleukin-12 (IL-12) and IL-23 Antagonists. Report Jun 27, 2008 258
Cytheris Announces Publication of IL-7 Oncology Data in The Journal of Experimental Medicine. Jun 26, 2008 904
Research and Markets: Essential Report on Interleukin-13 (IL-13) Antibodies Available Now. Report Jun 25, 2008 341
Dutton Associates Announces Investment Opinion: Interleukin Genetics Rating At Strong Speculative Buy In Update Coverage By Dutton Associates. Jun 18, 2008 486
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Wood, E.J. Jun 1, 2008 452
ZymoGenetics Announces Publication of Five IL-21 ASCO Abstracts. Clinical report May 16, 2008 1180
Dutton Associates Announces Investment Opinion: Interleukin Genetics Rating At Strong Speculative Buy In Update Coverage By Dutton Associates. Apr 29, 2008 488
Cytheris Announces New Phase I Study of Interleukin-7 As Immunotherapy In Treatment of Bone Marrow or Peripheral Blood Stem Cell Transplant Patients. Apr 23, 2008 677
Stimulation of Interleukin-4 production in EL4 T cells via increased NF-at binding activity by Scapharca broughtonii. Kim, Tae Sung; Yoo, Jin Cheol Report Apr 1, 2008 2453
Cytheris Announces 48-Week Results of Phase I/II Study Showing Administration of Interleukin-7 (IL-7) Significantly Improves CD4 T-Cell Counts in Chronically Infected HIV-1 Patients. Feb 13, 2008 1222
ZymoGenetics Begins Phase 2 Trial in Renal Cell Cancer Evaluating IL-21 Combined with Nexavar(R). Jan 8, 2008 883
ZymoGenetics Begins Phase 2 Clinical Trial of IL-21 in Melanoma. Dec 18, 2007 583
ZymoGenetics Presents Positive Interim Phase 1 Results for IL-21 in Combination with Rituxan(R) in B Cell Lymphoma. Dec 10, 2007 978
Linkage mapping of developmentally expressed cDNAS containing AT-rich elements in shrimp (Litopenaeus vannamei)--differential expression after challenge with Taura Syndrome virus (TSV). Dhar, Arun K.; Meehan-Meola, Dawn; Breland, Verlee; Carr, William H.; Lotz, Jeffrey M.; Alcivar-Warr Report Dec 1, 2007 6088
Dutton Associates Announces Investment Opinion: Interleukin Genetics Rating at Strong Speculative Buy in Initiating Coverage by Dutton Associates. Nov 6, 2007 493
Novel irreversible caspase-1 inhibitor attenuates the maturation of intracellular interleukin-1[beta]. Ma, Xue-Qin; Zhang, Hua-Jie; Zhang, Ya-Hui; Chen, Yi-Hua; Wu, Fang; Du, Jun-Qing; Yu, Hai-Ping; Zhou Feb 1, 2007 7803
Origins of ache: immune proteins may yield chronic-pain clues. Seppa, N Aug 19, 2006 543
HSIL in HIV+ girls. Brief Article Apr 1, 2005 199
Testosterone replacement curbs inflammatory cytokines. Jancin, Bruce May 1, 2004 359
AMT licenses rights on IL-10 for ex-vivo gene therapy. Brief Article Aug 1, 2002 410
Zymogenetics researchers identify novel protein with potential role in psoriasis. Brief Article Jan 1, 2001 348
Optimization Times for Measuring Stress-Induced Immunodepression at the Secreted IL2 and Secreted IL4 Level of the Immune Response. Wolk, Salem Brief Article Jan 1, 2001 181
Vical announces the issuance of United States Patent 6,147,055 for cancer treatment using gene-based, non-viral delivery of interleukin-2. Brief Article Nov 1, 2000 474
Targeting Interleukin-4 Receptors in Head and Neck Cancer. Oct 1, 2000 1711
Schering applies for patent. Brief Article Jan 1, 2000 28
Gene therapy using interleukin 12 successfully treats GVHD in mice. Jul 16, 1999 259
Hoffmann-La Roche obtains United States patent. Jan 1, 1999 71
Chiron Launches Proleukin in South Korea; Proprietary Cancer Treatment Now Approved in 47 Countries. Article Aug 12, 1998 265
Cytokine Networks Awarded Four Small Business Innovation Grants. Article Jul 22, 1998 717
Searle obtains United States patent Article Jun 1, 1998 54
Cytokine Networks Begins Clinical Trial of Compound to Inhibit Toxic Side Effects of IL-2 Cancer Therapy. May 28, 1998 556
Study shows IL-4 protein prevents diabetes. May 1, 1998 560
Amgen to Seek Corporate Partner to Develop Broad Inflammation Portfolio. Sep 4, 1997 484
Microbial trigger for autoimmunity? Travis, John Jun 21, 1997 648
GeneMedicine, Inc. Receives Clearance from the U.S. Food and Drug Administration to Commence Phase I Clinical Trial for its IL-2 Cancer Gene Medicine; GeneMedicine to receive a $500,000 milestone payment from Boehringer Mannheim. Feb 3, 1997 1057
Measles virus reveals its killing ways. Travis, John Jul 13, 1996 621
Death halts trial of kidney cancer drug. Seachrist, Lisa Jun 17, 1995 685
Number 12 steps up to bat; will this immune system messenger hit a grand slam? Pennsi, Elizabeth Cover Story Aug 20, 1994 3095
Three immune signals share receptor. Pennisi, E. Dec 18, 1993 651
Extending cell life yields clues to growth. Cowen, Ron Sep 29, 1990 598
Interleukin-1's secret message to ACTH. Edwards, Diane D. Oct 31, 1987 616
Psychiatric side-effects of interleukin-2. Weiss, R. Sep 26, 1987 593
A one-two punch for cancer. Dec 7, 1985 221

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles